Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: A cluster randomized controlled trial

Janita Pak Chun Chau, Suzanne Hoi Shan Lo, Kai Chow Choi, Vivian Wing Yan Lee, Grace Chung Yan Lui, Kam Ming Chan, Alexander Yuk Lun Lau, Janita Pak Chun Chau, Suzanne Hoi Shan Lo, Kai Chow Choi, Vivian Wing Yan Lee, Grace Chung Yan Lui, Kam Ming Chan, Alexander Yuk Lun Lau

Abstract

Introduction: Evidence has consistently shown the high efficacy of human papillomavirus (HPV) vaccines in preventing cervical cancers. However, the HPV vaccine uptake rate in Hong Kong is very low. We will develop and evaluate an innovative, theory-based multidisciplinary team-led school-based HPV vaccination health-promotion program (MDL-SHPVP), engaging female adolescents, parents/guardians, and secondary school personnel in multicomponent educational strategies and interactive discussions.

Methods and analysis: A cluster randomized controlled trial is proposed. We will recruit 2520 female adolescents and their parents/guardians from 18 secondary day schools. The MDL-SHPVP is underpinned by the Health Belief Model and Precaution Adoption Process Model. Multicomponent interventions will be offered, including education sessions with small group dialogues with a registered nurse and trained healthcare and lay volunteers, and educational computer games. A team of volunteers will be established to raise HPV, cervical cancer, and HPV vaccine awareness. Outcomes include adolescents' uptake of the HPV vaccine, adolescents' intention to receive HPV vaccination, vaccine acceptance among parents/guardians, and parents'/guardians' and adolescents' HPV knowledge, attitudes, and beliefs. Data will be collected at baseline, 1 month, and 1 year after intervention. The generalized estimating equations analysis will be used for comparing the outcomes between the 2 groups.

Ethics and dissemination: Ethical approval was obtained from the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee (Ref. no.: 2019.055). We will disseminate the study findings via peer-reviewed publications and presentations at relevant events and international and local conferences.

Trial registration number: ClinicalTrials.gov NCT04438291.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. World Health Organization. Cervical cancer. Available at: [accessed June 3, 2020].
    1. Oh JK, Weiderpass E. Infection and cancer: global distribution and burden of diseases. Ann Glob Health 2014;80:384–92..
    1. Centre for Health Protection. Cervical cancer. Available at: [accessed June 3, 2020].
    1. Harper DM, DeMars LR. HPV vaccines - a review of the first decade. Gynecol Oncol 2017;146:196–204..
    1. Lee LY, Garland SM. Human papillomavirus vaccination: the population impact. F1000Res 2017;6:866–77..
    1. Lehtinen M, Lagheden C, Luostarinen T, et al. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of three cohorts from randomized trials. BMJ Open 2017;7:e015867–75..
    1. Brisson M, Bénard É, Drolet M, et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health 2016;1:e8–17..
    1. Bruni L, Diaz M, Barrionuevo-Rosas L, et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health 2016;4:e453–63..
    1. Shapiro GK, Guichon J, Kelaher M. Canadian school-based HPV vaccine programs and policy considerations. Vaccine 2017;35:5700–7..
    1. Australian Government Department of Health. National Immunisation Program Schedule. Available at: [accessed June 3, 2020].
    1. The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong. Human papillomavirus (HPV) booklet. Available at: [accessed June 3, 2020].
    1. Loke AY, Kwan ML, Wong YT, et al. The uptake of human papillomavirus vaccination and its associated factors among adolescents: a systematic review. J Prim Care Community Health 2017;8:349–62..
    1. The Hong Kong Special Administrative Region of the People's Republic of China. The Chief Executive's 2018 Policy Address: VI. Improving People's Livelihood. Available at: [accessed June 3, 2020].
    1. Rose SB, Lawton BA, Lanumata T, et al. HPV/cervical cancer vaccination: parental preferences on age, place and information needs. J Prim Health Care 2010;2:190–8..
    1. Vercruysse J, Chigurupati NL, Fung L, et al. Parents’ and providers’ attitudes toward school-located provision and school-entry requirements for HPV vaccines. Hum Vaccin Immunother 2016;12:1606–14..
    1. Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs 2011;27:434–46..
    1. Yuen WWY, Lee A, Chan PKS, et al. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: facilitators and barriers among adolescent girls and their parents. PLoS One 2018;13:e0194159–74..
    1. Kessels SJ, Marshall HS, Watson M, et al. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine 2012;30:3546–56..
    1. Hendry M, Lewis R, Clements A, et al. HPV? Never heard of it!”: a systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination. Vaccine 2013;31:5152–67..
    1. Lee A, Ho M, Cheung CKM, et al. Factors influencing adolescent girls’ decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong. BMC Public Health 2014;14:925–35..
    1. Gamble HL, Klosky JL, Parra GR, et al. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol 2010;35:704–15..
    1. Fu LY, Bonhomme LA, Cooper SC, et al. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine 2014;32:1901–20..
    1. Grandahl M, Rosenblad A, Stenhammar C, et al. School-based intervention for the prevention of HPV among adolescents: a cluster randomised controlled study. BMJ Open 2016;6:e009875–86..
    1. Barnard M, George P, Perryman ML, et al. Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: implications from the Precaution Adoption Process Model. PLoS One 2017;12:e0182266–75..
    1. Kwan TTC, Tam KF, Lee PWH, et al. The effect of school-based cervical cancer education on perceptions towards human papillomavirus vaccination among Hong Kong Chinese adolescent girls. Patient Educ Couns 2011;84:118–22..
    1. Craig P, Dieppe P, Macintyre S, et al. Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. Int J Nurs Stud 2013;50:587–92..
    1. Centers for Disease Control and Prevention. HPV Vaccine Recommendations. Available at: [accessed June 3, 2020].
    1. Choi HC, Leung GM, Woo PP, et al. Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. Vaccine 2013;32:78–84..
    1. Li SL, Lau YL, Lam TH, et al. HPV vaccination in Hong Kong: uptake and reasons for non-vaccination amongst Chinese adolescent girls. Vaccine 2013;31:5785–8..
    1. Donner A, Klar N. Cluster randomization trials in epidemiology: theory and application. J Stat Plan Inference 1994;42:37–56..
    1. Adams G, Gulliford MC, Ukoumunne OC, et al. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol 2004;57:785–94..
    1. Hofman R, Schiffers PA, Richardus JH, et al. Increasing girls’ knowledge about human papillomavirus vaccination with a pre-test and a national leaflet: a quasi-experimental study. BMC Public Health 2013;13:611–8..
    1. Shapiro GK, Perez S, Naz A, et al. Investigating Canadian parents’ HPV vaccine knowledge, attitudes and behaviour: a study protocol for a longitudinal national online survey. BMJ Open 2017;7:e017814–22..
    1. McRee AL, Brewer NT, Reiter PL, et al. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis 2010;37:234–9..
    1. Dempsey AF, Fuhrel-Forbis A, Konrath S. Use of the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) in young adult women. PLoS One 2014;9:e100193–9..
    1. Sherman SM, Nailer E. Attitudes towards and knowledge about human papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK. PLoS One 2018;13:e0195801–17..
    1. Leyrat C, Morgan KE, Leurent B, et al. Cluster randomized trials with a small number of clusters: which analyses should be used? Int J Epidemiol 2018;47:321–31..
    1. Weberg D, Davidson S. Patient-centered care, evidence, and innovation. In: Davidson S, Weberg D, Porter-O’Grady T, et al., eds. Leadership for Evidence-based Innovation in Nursing and Health Professions. Burlington, MA: Jones & Bartlett Learning; 2017:111–141.
    1. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7..

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi